Bunkerhill Health · Jul 2026
Official Series B announcement; states total funding reached $55M, led by Khosla Ventures with participation from Sequoia Capital, Felicis, Optum Ventures, and Y Combinator.
Bunkerhill Health is building the system of action for health systems
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Bunkerhill Health is a San Francisco-based healthcare AI company whose Carebricks platform helps health systems build and deploy AI agents across clinical, operational, and administrative workflows; it also commercializes FDA-cleared imaging algorithms and reimbursement-enabled cardiovascular analysis.
Primary product
Carebricks
Founded
2021
Headquarters
San Francisco, California, United States
Team size
11-50
Industry
Hospitals and Health Care
Sub-industry
Healthcare AI / agentic AI platform for health systems
Offices
4 jobs at Bunkerhill Health
Business model
Stage
Series B
Total raised
$55M
Latest round
Series B · Jul 2026
Latest amount
$25M
Jul 2026 · Khosla Ventures
Mar 2023 · Sequoia Capital
Dec 2020 · Pacific 8 Ventures
Mar 2019 · Y Combinator
Leadership
Co-Founder and CEO
Co-Founder
VP, Forward Deployed AI
VP of Operations
Vice President of Implementations
Head of Strategic Partnerships
Chief of Staff
Public career pages describe a mission-driven culture rooted in persistence, collaboration, and the belief that healthcare can and must work better.
Visa sponsorship
Limited
Compensation
Public job postings show salary ranges around $140K-$245K depending on role, plus equity; some postings also mention benefits such as health/dental/vision coverage and 401(k).
Benefits
Pricing
Contact sales / enterprise contract pricing
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approx. $2.4M-$3.8M ARR (public 2024-2025 estimates)
Estimated monthly visits
5.4K
Traffic estimate as of Jun 2026
Bunkerhill Health · Jul 2026
Official Series B announcement; states total funding reached $55M, led by Khosla Ventures with participation from Sequoia Capital, Felicis, Optum Ventures, and Y Combinator.
Fortune · Jul 2026
Profiles the company’s origin and the move from scan-based AI to a broader health-system agent platform.
Business Wire · Apr 2026
Announces CMS reimbursement pathway and FDA clearances for Bunkerhill Contrast CAC and AVC on contrast-enhanced chest CTs.
Bunkerhill Health · Mar 2026
Highlights UTMB use of Carebricks for end-to-end workflows and real-world AI operationalization.
Bunkerhill Health · Jun 2025
Announces expanded UTMB deployment of Carebricks for broader clinical reasoning and workflow automation.